Skip to content

POMX (Post Operative Morbidity): randomized controlled trial of chewing gum to reduce postoperative morbidity in elective orthopaedic surgery

POMX (Post Operative Morbidity): randomized controlled trial of chewing gum to reduce postoperative morbidity in elective orthopaedic surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN20301599
Enrollment
106
Registered
2011-09-29
Start date
2011-09-01
Completion date
Unknown
Last updated
2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Topic: Oral and Gastrointestinal, Generic Health Relevance and Cross Cutting Themes

Interventions

Clinical assessment, including examination, electrocardiogram (ECG), basic physiological observations

Sponsors

University College London (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients undergoing elective orthopaedic hip and knee arthroplasty procedures and meet the following criteria: 1. American Society of Anaesthesiologists risk grade 14 2. Age > 40 years 3. Have received a general anaesthetic with/without peripheral nerve block Target Gender: Male & Female; Upper Age Limit 90 years ; Lower Age Limit 30 years

Exclusion criteria

Exclusion criteria: 1. Refusal of consent 2. Preoperative nasogastric feeding 3. Gastrostomy feeding 4. Preoperative impaired swallowing

Design outcomes

Primary

MeasureTime frame
Not provided at time of registration

Secondary

MeasureTime frame
Not provided at time of registration

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 15, 2026